Zernica, Poland

Wieslaw Szeja

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Instytut Farmaceutyczny. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wieslaw Szeja. Retrieved from https://idiyas.com/inventor/wieslaw-szeja

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Wieslaw Szeja

Introduction

Wieslaw Szeja is a notable inventor based in Zernica, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mucopolysaccharidoses. With a total of two patents to his name, Szeja's work is recognized for its potential impact on medical treatments.

Latest Patents

Szeja's latest patents focus on the use of isoflavones for treating mucopolysaccharidoses. The method involves administering a therapeutically effective amount of a natural isoflavone, its derivatives, or pharmaceutically acceptable salts to patients in need of treatment. These patents detail a pharmaceutical composition that includes a natural isoflavone, which is crucial for the effective treatment of this condition.

Career Highlights

Wieslaw Szeja is affiliated with the Instytut Farmaceutyczny, where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

Szeja collaborates with notable colleagues, including Grzegorz Grynkiewicz and Grzegorz Wegrzyn. Their combined expertise contributes to the innovative research being conducted at the institute.

Conclusion

Wieslaw Szeja's contributions to the field of pharmaceuticals, particularly through his patents on isoflavones, highlight his role as an influential inventor. His work has the potential to significantly impact the treatment of mucopolysaccharidoses, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…